SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-19-005435
Filing Date
2019-08-23
Accepted
2019-08-23 18:01:53
Documents
1
Period of Report
2019-08-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-45529.html 4  
1 PRIMARY DOCUMENT marketforms-45529.xml 4 7232
  Complete submission text file 0001214659-19-005435.txt   8640
Mailing Address C/O ZYMOGENETICS, INC. 1201 EASTLAKE AVENUE SEATTLE WA 98102
Business Address
CARTER BRUCE L A (Reporting) CIK: 0001225503 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 191050227

Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations